A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: intensify (9), increase (1000), strengthen (85), magnify (5), augment (17), enlarge (31)

Using your smartphone to help you hear - patient information

Description
If you have a long-term hearing loss, hearing aids are the best option to help improve your hearing. If you
Url
/Media/UHS-website-2019/Patientinformation/Audiology/Using-your-smartphone-to-help-you-hear-3450-PIL.pdf

Papers Trust Board - 15 July 2025

Description
Agenda Trust Board – Open Session Date 15/07/2025 Time 9:00 - 13:00 Location Conference Room, Heartbeat Education Centre Chair
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-15-July-2025.pdf

WHP Funding Call 2

Description
Funding Call 2 About Wessex Health Partners: • Wessex Health Partners (WHP) is the region’s academic health science strategic partnership of NHS and HEI organisati
Url
/Media/Southampton-Clinical-Research/Downloads/WHP-Funding-Call-2.pdf

Carboplatin-Docetaxel-Trastuzumab

Description
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC6)-DOCETAXEL-TRASTUZUMAB (TCH) Regimen • Breast Cancer – Carboplatin (AUC6)-Docetaxel-Trastuzumab (TCH) Indication • Adjuvant treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Docetaxel-Trastuzumab.pdf

WHP Funding Call EOI_01.03.24

Description
Funding Call – Round 1 - PILOT Expression of Interest About Wessex Health Partners: 1. Wessex Health Partners (WHP) is the region’s academic health science strate
Url
/Media/Southampton-Clinical-Research/Downloads/WHP-Funding-Call-EOI-01.03.24.docx

BEACON protocol v8.0 07Mar2023 signed

Description
A randomised phase IIb trial of BE AC v izumab added to Temozolomide O ± Irin tecan for children with N refractory
Url
/Media/UHS-website-2019/Docs/PaediatricOncology/beacon-protocol-v8.0-07mar2023-signed.pdf

Carboplatin-Docetaxel-Pertuzumab-Trastuzumab_IV-SC

Description
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC6)-DOCETAXEL- PERTUZUMABTRASTUZUMAB (IV/SC) Regimen • Breast Cancer – Carboplatin (AUC6)-Docetaxel-Pertuzumab-Trastuzumab (IV/SC) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Docetaxel-Pertuzumab-Trastuzumab-IV-SC.pdf

Carboplatin-Docetaxel-Pertuzumab-Trastuzumab_IV

Description
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC 6)-DOCETAXEL-PERTUZUMABTRASTUZUMAB (IV) Regimen • Breast Cancer – Carboplatin (AUC6)-Docetaxel-Pertuzumab-Trastuzumab (IV) Indication • Neo
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Docetaxel-Pertuzumab-Trastuzumab-IV.pdf

UHS AR 23-24 Final

Description
2023/24 Incorporating the quality account University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2023/24 Presented to Parliament
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/UHS-AR-23-24-Final.pdf

PDF document

Description
Originally uploaded to http://cdn.flamehaus.com/Valve_Handbook_LowRes.pdf Handbook courtesy of Valve HANDBOOK FOR NEW EMPLOYEES ============================================================ HANDBOOK FOR NEW EMPLOYEES
Url
/Media/UHS-website-2019/Docs/Zengenti-Mock/PDF-document.pdf
1 to 10 of 10